CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience.

Angeliki AndrikopoulouOraianthi FisteKleoniki ApostolidouEfthymia SkafidaChristos MarkellosMichalis LiontosAnastasios KyriazoglouMeletios- Athanasios DimopoulosFlora Zagouri

Published in: Medical sciences (Basel, Switzerland) (2021)

Though our data reflect a small sample size, we report a reduced arthralgia rate (6.4%) during treatment with CDK4/6 inhibitors compared with that reported in studies of AIs (20-47%).

Keyphrases

cell cycle
electronic health record
big data
cell proliferation
case control